Cudarolimab (IBI101) is a completely human anti-OX40 (CD134, a co stimulating molecule expressed by activated immune cells) antibody. Cudarolimab inhibits the binding of OX40 to its ligand OX40L. Cudarolimab has antitumor activity and can be used in cancer related research.
CAS Number:
[2244739-29-3]
Target:
OX Receptor
* VAT and and shipping costs not included. Errors and price changes excepted